CA
ICUI icon

Claris Advisors’s ICU Medical ICUI Stock Holding History

Claris Advisors’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$182 – 566
2024
Q3 		$182 Buy
+1
New +$148 ﹤0.01% 988

Other funds holding ICUI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Claris Advisors's ICUI Position: Q4 2024 in Review

Claris Advisors sold out of ICU Medical (ICUI) in Q4 2024, closing a stake of 1 share — an estimated $182 sold.

Claris Advisors first reported a position in ICUI in Q3 2024 and held it in 1 quarter. The position peaked at $182 in Q3 2024. 286 funds tracked by Wall St. Rank hold ICUI as of Q4 2024.

  • Claris Advisors reported no remaining ICU Medical position as of Q4 2024 after selling out during the quarter.
  • Claris Advisors sold 1 ICU Medical share in Q4 2024, an estimated $182.
  • Claris Advisors first reported a position in ICU Medical in Q3 2024 and held it in 1 quarter.
  • Claris Advisors's ICU Medical position peaked at $182 in Q3 2024.
  • 286 funds tracked by Wall St. Rank held ICU Medical as of Q4 2024.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.